FDA cites Granules, a large Indian generic drug manufacturer, for tossing truckloads of important documents from a facility ...

Amid layoffs and a disintegrating share price, former investor darling Ginkgo Bioworks is trying out a new tack to find ...

WASHINGTON — Sen. Bill Cassidy (La.), a key Republican senator with seats on the chamber’s health and finance committees, ...

GLP-1 based drugs are transforming the treatment of obesity and opening up new avenues for addressing heart disease, ...

STAT's podcast The Readout LOUD this week discusses cannabinoid receptor drugs in weight loss, what the Fed's rates cut might ...

A Senate committee voted to hold Ralph de la Torre, CEO of troubled Steward Health Care, in contempt. If the full Senate ...

The Federal Reserve yesterday cut interest rates by 50 basis points, in its first time cutting rates in four years. And how ...

A group of lawmakers wants the U.S. Patent & Trademark Office and drug companies to change their approach toward handling ...

As for Amazon, it’s staying true to it’s legacy as an online store. Invitations described the event as an opportunity to ...

Serial biotech founder George Church has a new startup, and this time, he has skin in the game, quite literally.

The program gives manufacturers better access to regulators and the ability to design more flexible clinical trials.

A House committee on Wednesday passed a bill to renew a program aimed at aiding development of drugs for rare diseases in ...